S
Shionogi & Co Ltd
TSE:4507
Shionogi & Co Ltd
TSE:4507
Price:
3 474
JPY
1.88%
Market Closed
Market Cap:
¥3.1T
Relative Value
The Relative Value of one Shionogi & Co Ltd stock under the Base Case scenario is 1 800.2 JPY. Compared to the current market price of 3 474 JPY, Shionogi & Co Ltd is Overvalued by 48%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
1 800.2
JPY
Overvaluation 48%
S
Multiples Across Competitors
Competitors Multiples
Shionogi & Co Ltd Competitors
Shionogi & Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| JP |
S
|
Shionogi & Co Ltd
TSE:4507
|
3T JPY | 6.4 | 15.2 | 12.1 | 13.5 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
908.7B USD | 13.7 | 43.2 | 29.1 | 31.1 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
581.3B USD | 6.2 | 21.7 | 15 | 18.5 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
256.6B CHF | 4.2 | 19.9 | 11.8 | 13.3 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
224.3B GBP | 5.1 | 29.3 | 16.2 | 22.9 | |
| CH |
|
Novartis AG
SIX:NOVN
|
233.8B CHF | 5.4 | 21.6 | 13.3 | 17.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
288.4B USD | 4.4 | 15.8 | 9.8 | 11.9 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.6 | 11 | 8.1 | 9.5 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.5B USD | 2.5 | 20 | 7.7 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122B USD | 2.5 | 17.3 | 7.3 | 8.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
